𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mechanism of action of new Alzheimer's therapeutic in phase III clinical trials

✍ Scribed by Mullan, Michael; Bachmeier, Corbin; Ait-Ghezala, Ghania; Beaulieu-Abdelahad, David; Crawford, Fiona; Abdullah, Laila; Kenny, Rose Anne; Kennelly, Sean; Lawlor, Brian; Paris, Daniel

Book ID
123556220
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
48 KB
Volume
7
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical Trials || Mechanisms of Action,
Clinical Trials || Mechanisms of Action, Part III – Immune Disorders
✍ Brody, Tom πŸ“‚ Article πŸ“… 2012 πŸ› Elsevier 🌐 English βš– 291 KB

*Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines* is a practical guidebook for those engaged in clinical trial design. This book details the organizations and content of clinical trials, including trial design, safety, endpoints, subgroups, HRQoL, con